Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Buchfelder

Showing results (211-220 of 212) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 212 results.
Endocrine-Related Cancer|January 16, 2019
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngiomaG Carreno, J K R Boult, J Apps, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.
Pageof 22

Showing results (211-220 of 212) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 212 results.
Endocrine-Related Cancer|January 16, 2019
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngiomaG Carreno, J K R Boult, J Apps, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statementB M K Biller, A B Grossman, P M Stewart, et al.
Pageof 22